159 related articles for article (PubMed ID: 25205549)
1. Combined immune deficiency in a patient with a novel NFKB2 mutation.
Lindsley AW; Qian Y; Valencia CA; Shah K; Zhang K; Assa'ad A
J Clin Immunol; 2014 Nov; 34(8):910-5. PubMed ID: 25205549
[TBL] [Abstract][Full Text] [Related]
2. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies.
Brue T; Quentien MH; Khetchoumian K; Bensa M; Capo-Chichi JM; Delemer B; Balsalobre A; Nassif C; Papadimitriou DT; Pagnier A; Hasselmann C; Patry L; Schwartzentruber J; Souchon PF; Takayasu S; Enjalbert A; Van Vliet G; Majewski J; Drouin J; Samuels ME
BMC Med Genet; 2014 Dec; 15():139. PubMed ID: 25524009
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency.
Chen K; Coonrod EM; Kumánovics A; Franks ZF; Durtschi JD; Margraf RL; Wu W; Heikal NM; Augustine NH; Ridge PG; Hill HR; Jorde LB; Weyrich AS; Zimmerman GA; Gundlapalli AV; Bohnsack JF; Voelkerding KV
Am J Hum Genet; 2013 Nov; 93(5):812-24. PubMed ID: 24140114
[TBL] [Abstract][Full Text] [Related]
4. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100.
Lee CE; Fulcher DA; Whittle B; Chand R; Fewings N; Field M; Andrews D; Goodnow CC; Cook MC
Blood; 2014 Nov; 124(19):2964-72. PubMed ID: 25237204
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in
Klemann C; Camacho-Ordonez N; Yang L; Eskandarian Z; Rojas-Restrepo JL; Frede N; Bulashevska A; Heeg M; Al-Ddafari MS; Premm J; Seidl M; Ammann S; Sherkat R; Radhakrishnan N; Warnatz K; Unger S; Kobbe R; Hüfner A; Leahy TR; Ip W; Burns SO; Fliegauf M; Grimbacher B
Front Immunol; 2019; 10():297. PubMed ID: 30941118
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency.
Petersheim D; Massaad MJ; Lee S; Scarselli A; Cancrini C; Moriya K; Sasahara Y; Lankester AC; Dorsey M; Di Giovanni D; Bezrodnik L; Ohnishi H; Nishikomori R; Tanita K; Kanegane H; Morio T; Gelfand EW; Jain A; Secord E; Picard C; Casanova JL; Albert MH; Torgerson TR; Geha RS
J Allergy Clin Immunol; 2018 Mar; 141(3):1060-1073.e3. PubMed ID: 28629746
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in the Nfkb2 gene generates an NF-kappa B2 "super repressor".
Tucker E; O'Donnell K; Fuchsberger M; Hilton AA; Metcalf D; Greig K; Sims NA; Quinn JM; Alexander WS; Hilton DJ; Kile BT; Tarlinton DM; Starr R
J Immunol; 2007 Dec; 179(11):7514-22. PubMed ID: 18025196
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.
Yeo SK; French R; Spada F; Clarkson R
Breast Cancer Res Treat; 2017 Apr; 162(3):465-477. PubMed ID: 28190248
[TBL] [Abstract][Full Text] [Related]
9. Novel nonsense gain-of-function
Kuehn HS; Niemela JE; Sreedhara K; Stoddard JL; Grossman J; Wysocki CA; de la Morena MT; Garofalo M; Inlora J; Snyder MP; Lewis DB; Stratakis CA; Fleisher TA; Rosenzweig SD
Blood; 2017 Sep; 130(13):1553-1564. PubMed ID: 28778864
[TBL] [Abstract][Full Text] [Related]
10. A Nonsense N -Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency.
Kuehn HS; Bernasconi A; Niemela JE; Almejun MB; Gallego WAF; Goel S; Stoddard JL; Sánchez RGP; Franco CAA; Oleastro M; Grunebaum E; Ballas Z; Cunningham-Rundles C; Fleisher TA; Franco JL; Danielian S; Rosenzweig SD
J Clin Immunol; 2020 Nov; 40(8):1093-1101. PubMed ID: 32813180
[TBL] [Abstract][Full Text] [Related]
11. A Case Report of Hypoglycemia and Hypogammaglobulinemia: DAVID Syndrome in a Patient With a Novel NFKB2 Mutation.
Lal RA; Bachrach LK; Hoffman AR; Inlora J; Rego S; Snyder MP; Lewis DB
J Clin Endocrinol Metab; 2017 Jul; 102(7):2127-2130. PubMed ID: 28472507
[TBL] [Abstract][Full Text] [Related]
12. Balance between NF-κB p100 and p52 regulates T cell costimulation dependence.
Giardino Torchia ML; Conze DB; Jankovic D; Ashwell JD
J Immunol; 2013 Jan; 190(2):549-55. PubMed ID: 23248260
[TBL] [Abstract][Full Text] [Related]
13.
Papoutsopoulou S; Tang J; Elramli AH; Williams JM; Gupta N; Ikuomola FI; Sheibani-Tezerji R; Alam MT; Hernández-Fernaud JR; Caamaño JH; Probert CS; Muller W; Duckworth CA; Pritchard DM
Am J Physiol Gastrointest Liver Physiol; 2022 Oct; 323(4):G306-G317. PubMed ID: 35916405
[TBL] [Abstract][Full Text] [Related]
14. Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
Guo X; Koff JL; Moffitt AB; Cinar M; Ramachandiran S; Chen Z; Switchenko JM; Mosunjac M; Neill SG; Mann KP; Bagirov M; Du Y; Natkunam Y; Khoury HJ; Rossi MR; Harris W; Flowers CR; Lossos IS; Boise LH; Dave SS; Kowalski J; Bernal-Mizrachi L
Oncogene; 2017 Jul; 36(29):4224-4232. PubMed ID: 28368397
[TBL] [Abstract][Full Text] [Related]
15. Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility.
Wirasinha RC; Davies AR; Srivastava M; Sheridan JM; Sng XYX; Delmonte OM; Dobbs K; Loh KL; Miosge LA; Lee CE; Chand R; Chan A; Yap JY; Keller MD; Chen K; Rossjohn J; La Gruta NL; Vinuesa CG; Reid HH; Lionakis MS; Notarangelo LD; Gray DHD; Goodnow CC; Cook MC; Daley SR
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33107914
[TBL] [Abstract][Full Text] [Related]
16. NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential.
De Leo P; Gazzurelli L; Baronio M; Montin D; Di Cesare S; Giancotta C; Licciardi F; Cancrini C; Aiuti A; Plebani A; Cicalese MP; Lougaris V; Fousteri G
Clin Immunol; 2020 Jan; 210():108309. PubMed ID: 31751612
[TBL] [Abstract][Full Text] [Related]
17. Early B cell developmental impairment with progressive B cell deficiency in NFKB2 mutated CVID disease without autoimmunity.
Lougaris V; Moratto D; Baronio M; Lorenzini T; Rossi S; Gazzurelli L; Bondioni MP; Plebani A
Clin Immunol; 2019 Aug; 205():153-155. PubMed ID: 30500415
[TBL] [Abstract][Full Text] [Related]
18. Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation.
Ramakrishnan KA; Rae W; Barcenas-Morales G; Gao Y; Pengelly RJ; Patel SV; Kumararatne DS; Ennis S; Döffinger R; Faust SN; Williams AP
J Allergy Clin Immunol; 2018 Apr; 141(4):1479-1482.e6. PubMed ID: 29225085
[No Abstract] [Full Text] [Related]
19. The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.
Zhang Z; Wang Y; Li C; Shi Z; Hao Q; Wang W; Song X; Zhao Y; Jiao S; Zhou Z
J Biol Chem; 2015 Aug; 290(32):19558-68. PubMed ID: 26112410
[TBL] [Abstract][Full Text] [Related]
20. Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.
Wang HY; Ma CA; Zhao Y; Fan X; Zhou Q; Edmonds P; Uzel G; Oliveira JB; Orange J; Jain A
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5127-32. PubMed ID: 23493554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
